Cancer State Therapeutics SRL
6.6 FTECancer State Therapeutics reported total assets of €3.96m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 May 2026), with 6.6 full-time equivalents.
By total assets for 2025, Cancer State Therapeutics ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Cancer State Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +324 % Total assets +194 % Headcount (avg FTE) +200 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cancer State Therapeutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 May 2026
- Year ended 31 Dec 2024filed on 30 May 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
Cancer State Therapeutics's financial analysis
- Solvency94.4%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cancer State Therapeutics
7 active director(s) in the register.
and 1 more
Cancer State Therapeutics's shareholders and holdings →Cancer State Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0793.113.273
- VAT number
- BE0793113273
- Peppol
- Registered · 0208:0793113273 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Oct 2022
- Registered office
- 6041 Charleroi
- Size
- Micro · 6.6 FTE
- Latest accounts
- 2025 · filed on 15 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Cancer State Therapeutics (SRL) has been based in Charleroi since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 690,490 € and equity of €3.74m; its revenue is not published. With 6.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 94.4%, above the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cancer State Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- Santero Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.15m
- Zymofix Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.41m
- Nanocyl Research and experimental development on natural sciences and engineering Sambreville · balance sheet €13.2m
- BiometrIQ Research and experimental development on natural sciences and engineering Kortrijk · balance sheet €1.65m
- Protealis Research and experimental development on natural sciences and engineering Ghent · balance sheet €11.1m
- Dendrogenix Research and experimental development on natural sciences and engineering Liège · balance sheet €5.28m
- Nexelis Europe Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.65m
- H2WIN Research and experimental development on natural sciences and engineering Nivelles · balance sheet €7.36m
Frequently asked questions about Cancer State Therapeutics
What is the revenue of Cancer State Therapeutics?
Cancer State Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cancer State Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0793113273 for Cancer State Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0793.113.273.
Where is the registered office of Cancer State Therapeutics?
According to the CBE register, the registered office of Cancer State Therapeutics is in 6041 Charleroi.
What is the equity of Cancer State Therapeutics?
At the close of the 2025 financial year, the equity of Cancer State Therapeutics amounts to 3,738,662 €, a solvency of 94.4% of total assets.
How many people work at Cancer State Therapeutics?
6.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cancer State Therapeutics?
The register lists 7 active mandates at Cancer State Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Cancer State Therapeutics within its sector?
By total assets for 2025, Cancer State Therapeutics ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Cancer State Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →